Where does RegenLab USA LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), RegenLab USA LLC ranks #21,678 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does RegenLab USA LLC hold?

RegenLab USA LLC holds 13 US utility patents granted between 2018 and 2024, spanning 8 technology areas.

What is RegenLab USA LLC's Innovation Score?

RegenLab USA LLC has an Innovation Score of 35.3 out of 100 (top 50% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does RegenLab USA LLC focus on?

RegenLab USA LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 13 patents, ranking #1,479 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is RegenLab USA LLC's patent grant rate increasing or decreasing?

RegenLab USA LLC's recent grant velocity is +17% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for RegenLab USA LLC's patents?

RegenLab USA LLC's patents average 21.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the RegenLab USA LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

RegenLab USA LLC

USPTO PatentsView assignee record - 13 granted patents across 8 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Regenlab ranks #21,678 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 8 technology areas.

#21,678
of 49,997 US assignees by volume: Top 50%
by Innovation Score (35.3/100): 21.4
avg claims per patent: +17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21678 · US Corporation #21,678 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,678/49,997
PHOTO-FINISH Red Viking Group
CPC-NARROW A61P · 8 areas
INNOV-THIN 35.3/100
CLAIMS-DENSE 21.4 claims/avg
TYPE-USCORP US Corporation
VEL-UP +17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Red Viking Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Regenlab’s 35.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (26%) Velocity 3.3 pts (9%) Breadth 10.0 pts (28%) Claim depth 12.8 pts (36%)

Qualcomm Incorporated · highest

85
RegenLab USA · this assignee

35
3D Lighting… · lowest

7

What this shows Regenlab's Innovation Score is 35.3/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Regenlab?

Each dot is one of Regenlab’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Regenlab’s own 21.4 claims/patent is ABOVE the 18.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Regenlab vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Regenlab's grants concentrate

RegenLab USA LLC is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2024. By volume, Regenlab sits between Red Viking Group, Inc. and Renovia Inc..

Regenlab's three-year grant acceleration

RegenLab USA LLC shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Red Viking Group

13
Redshift Bioanaly…

13
Redwood Robotics

13
Refratechnik Hold…

13
Relamp

13
Relay Therapeutics

13
Relypsa

13
Renovia

13
Regenlab USA ◀

13

What this shows RegenLab holds 13 patents at rank #21,692, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near RegenLab

By rank, the assignees closest to #21,692 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in RegenLab's primary technology class.

Regenlab's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

RegenLab USA LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	4	30.8%
2019	2	15.4%
2021	4	30.8%
2022	2	15.4%
2024	1	7.7%

Which technologies does RegenLab USA LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 13

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 12

C12Y - Enzymes 12

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 12

A61B - DIAGNOSIS; SURGERY; Identification 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

RegenLab USA LLC's patent record in context - here's where to go next.

RegenLab USA LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #21,678 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare RegenLab USA LLC against Red Viking Group, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.